Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Moelis & Company (MC) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Capital Markets
$56.57
-0.20 (-0.35%)10 Quality Stocks Worth Considering Now
Researching Moelis (MC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MC and similar high-potential opportunities.
Based on our analysis of 18 Wall Street analysts, MC has a neutral consensus with a median price target of $51.00 (ranging from $42.00 to $69.00). The overall analyst rating is Hold (5.3/10). Currently trading at $56.57, the median forecast implies a -9.8% downside. This outlook is supported by 1 Buy, 5 Hold, and 2 Sell ratings.
The most optimistic forecast comes from James Mitchell at Buckingham Research, projecting a 22.0% upside. Conversely, the most conservative target is provided by Ryan Kenny at Morgan Stanley, suggesting a 25.8% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 15, 2025 | Goldman Sachs | James Yaro | Neutral | Maintains | $63.00 |
Apr 24, 2025 | JMP Securities | Devin Ryan | Market Perform | Reiterates | $0.00 |
Apr 24, 2025 | JP Morgan | Kenneth Worthington | Neutral | Maintains | $52.00 |
Apr 24, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $50.00 |
Apr 8, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $55.00 |
Apr 7, 2025 | Morgan Stanley | Ryan Kenny | Underweight | Maintains | $42.00 |
Mar 14, 2025 | Goldman Sachs | James Yaro | Neutral | Maintains | $75.00 |
Mar 13, 2025 | Morgan Stanley | Ryan Kenny | Underweight | Downgrade | $70.00 |
Feb 6, 2025 | JMP Securities | Devin Ryan | Market Perform | Reiterates | $0.00 |
Feb 6, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $83.00 |
Feb 6, 2025 | Morgan Stanley | Ryan Kenny | Overweight | Maintains | $100.00 |
Feb 6, 2025 | Keefe, Bruyette & Woods | Aidan Hall | Outperform | Reiterates | $92.00 |
Feb 6, 2025 | Goldman Sachs | James Yaro | Neutral | Maintains | $87.00 |
Jan 14, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $77.00 |
Dec 20, 2024 | Keefe, Bruyette & Woods | Aidan Hall | Outperform | Upgrade | $86.00 |
Dec 12, 2024 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $78.00 |
Dec 9, 2024 | Morgan Stanley | Ryan Kenny | Overweight | Upgrade | $92.00 |
Oct 24, 2024 | Morgan Stanley | Ryan Kenny | Underweight | Maintains | $66.00 |
Oct 8, 2024 | UBS | Brennan Hawken | Sell | Maintains | $60.00 |
Sep 23, 2024 | Morgan Stanley | Ryan Kenny | Underweight | Maintains | $67.00 |
The following stocks are similar to Moelis based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Moelis & Company has a market capitalization of $4.23B with a P/E ratio of 25.9x. The company generates $1.28B in trailing twelve-month revenue with a 13.2% profit margin.
Revenue growth is +41.0% quarter-over-quarter, while maintaining an operating margin of +12.0% and return on equity of +39.2%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides strategic financial advisory services.
The company generates revenue by offering expert financial advice on mergers and acquisitions, recapitalizations, restructurings, and capital markets transactions to a wide range of clients including corporations, governments, and individuals. Its client-centered approach allows for tailored financial solutions, ensuring the firm meets specific client needs effectively.
Moelis & Company, established in 2007 and headquartered in New York City, operates in various sectors such as healthcare, technology, and real estate. With a strong international presence in major financial hubs, it has built a reputation as a trusted advisor in the global investment banking landscape.
Financial Services
Capital Markets
1,308
Mr. Kenneth David Moelis
United States
2014
Moelis strengthens its Private Funds Advisory business by appointing Jeff Hammer and Paul Sanabria, indicating growth and expansion in this sector.
Moelis strengthening its Private Funds Advisory with key hires may enhance its market position, potentially leading to increased deal flow and revenue, positively impacting investor confidence.
MC reported Q1 2025 results exceeding estimates, driven by increased revenues and other income, despite higher expenses impacting overall performance.
MC's better-than-expected Q1 2025 results indicate strong revenue growth, which can boost investor confidence, but rising expenses may signal potential profitability concerns.
Moelis & Company (NYSE: MC) will host its Q1 2025 Earnings Conference Call on April 23, 2025, at 5:00 PM ET, featuring key executives and analysts from major financial institutions.
The upcoming earnings call for Moelis & Company will provide insights into the firm's financial performance and strategies, influencing investor sentiment and stock valuation.
Moelis & Company has announced its First Quarter 2025 financial results and declared a quarterly dividend of $0.65 per share.
Moelis & Company's solid quarterly results and consistent dividend signal financial health, potentially attracting income-focused investors and reflecting stability in their operations.
Moelis (MC) reported quarterly earnings of $0.64 per share, exceeding the Zacks Consensus Estimate of $0.57 and up from $0.22 per share year-over-year.
Moelis' earnings beat expectations and show significant year-over-year growth, indicating strong financial performance and potential for increased investor confidence and stock value.
Moelis (MC) is expected to lack the necessary factors for a potential earnings beat in its upcoming report. Investors should be aware of key expectations ahead of the announcement.
Moelis (MC) may underperform in its upcoming earnings report, indicating potential weakness in financial performance, which could negatively impact its stock price and investor sentiment.
Based on our analysis of 18 Wall Street analysts, Moelis & Company (MC) has a median price target of $51.00. The highest price target is $69.00 and the lowest is $42.00.
According to current analyst ratings, MC has 1 Buy ratings, 5 Hold ratings, and 2 Sell ratings. The stock is currently trading at $56.57. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict MC stock could reach $51.00 in the next 12 months. This represents a -9.8% decrease from the current price of $56.57. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by offering expert financial advice on mergers and acquisitions, recapitalizations, restructurings, and capital markets transactions to a wide range of clients including corporations, governments, and individuals. Its client-centered approach allows for tailored financial solutions, ensuring the firm meets specific client needs effectively.
The highest price target for MC is $69.00 from James Mitchell at Buckingham Research, which represents a 22.0% increase from the current price of $56.57.
The lowest price target for MC is $42.00 from Ryan Kenny at Morgan Stanley, which represents a -25.8% decrease from the current price of $56.57.
The overall analyst consensus for MC is neutral. Out of 18 Wall Street analysts, 1 rate it as Buy, 5 as Hold, and 2 as Sell, with a median price target of $51.00.
Stock price projections, including those for Moelis & Company, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.